3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Lung Neoplasms
2
Hypoxia
2
Emergence Delirium
2
Urinary Bladder Neoplasms
1
Tuberculosis, Pulmonary
1
Thoracic Diseases
1
Stomach Neoplasms
1
Respiratory Aspiration
1
Recurrence
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Intraoral Tumor
1
Hepatic Tumor Resection
1
Delirium
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
89
Carboplatin
79
Specimen Handling
76
Magnetic Resonance Spectroscopy
63
Pemetrexed
60
Cisplatin
48
durvalumab
44
Paclitaxel
38
Nivolumab
34
atezolizumab
32
osimertinib
29
Radiotherapy
29
Radiosurgery
29
Biopsy
26
Blood Specimen Collection
25
Gemcitabine
24
Docetaxel
24
Immunoglobulin G
23
Disulfides
22
Standard of Care
21
Drug Therapy
21
Etoposide
19
Taxes
18
Radiation
18
Practice Guidelines as Topic
18
Educational Status
16
130-nm albumin-bound paclitaxel
15
X-Rays
14
Surveys and Questionnaires
14
Bevacizumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Propofol
×
1 year
×
Clear all
NCT06330038
2026-04-20
GASTIVA
Samsung Medical Center
Phase 4
Recruiting
5,384 enrolled
NCT07028593
2026-01-28
CP-MINS
Tongji Hospital
Phase 4
Recruiting
1,058 enrolled